2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Targeting GPi: DBS Treating Dystonia in a Patient with Wilson’s Disease

L. Sperry, X. Duan, F. Girgis, K. Denny, S. Farias, D. Kahn, V. Medici, L. Zhang, K. Shahlaie (Sacramento, CA, USA)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Teed and primary cell longevity: Results from product surveillance registry

P. Konrad, G. Plotkin, S. Palfi, E. Cuny, J-P. Azulay, T. Witt, T. Theys, Y. Temel, G. Johnson, K. Bhatia, T. Weaver, M. Schiess, J. Krauss, S. Falowski (Nashville, TN, USA)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Thalamic deep brain stimulation of the ventral intermediate nucleus in patients with dystonic head tremor

M. Wolf, C. Blahak, A. Saryyeva, J. Runge, J. Krauss (Mannheim, Germany)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

The Adaptation of Card Games for Education in Movement Disorders

S. Schaefer, A. Vives Rodriguez (New Haven, CT, USA)

Education in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

The Akt/mTOR/P70S6K/4EB-P1 signaling pathway is activated by metformin in a toxin-induced cellular model of Parkinson’s disease

P. Dharmasaroja, P. Chanthammachat (Bangkok, Thailand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

The anti-dyskinetic effect of the clinically-available 5-HT3 receptor antagonist granisetron in the 6-OHDA-lesioned rat model of Parkinson’s disease

C. Kwan, I. Frouni, D. Bedard, A. Hamadjida, P. Huot (Montreal, QC, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

The BeyoND study: Design and baseline characteristics of a study evaluating the long-term safety of ND0612 for motor fluctuations in Parkinson’s disease

W. Poewe, F. Stocchi, A. Espay, T. Rachmilewitz Minei, S. Oren, R. Case, K. Kieburtz, C. Olanow (Innsbruck, Austria)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

The change of heart rate variability after subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease: A Meta⁃analysis

X.Y. Luo, R. Ou, H.F. Shang (Chengdu, People’s Republic of China)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

The combined effect of repetitive transcranial magnetic stimulation and treadmill training in people with Parkinson’s disease – A randomized controlled trial

C. Chung, M. Mak, M. AuYeung, Y. Chan, N. Cheung, V. Mok, M. Hallett (Hong Kong, Hong Kong)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)

Myoclonus  ·  Hall 3FG